Dermata Therapeutics, Inc. (DRMA)
NASDAQ: DRMA · Real-Time Price · USD
1.200
+0.020 (1.69%)
Jul 30, 2026, 11:37 AM EDT - Market open
Dermata Therapeutics Employees
Dermata Therapeutics had 9 employees as of December 31, 2025. The number of employees increased by 1 or 12.50% compared to the previous year.
Employees
9
Change (1Y)
1
Growth (1Y)
12.50%
Revenue / Employee
n/a
Profits / Employee
-$789,186
Market Cap
4.83M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 9 | 1 | 12.50% |
| Dec 31, 2024 | 8 | 0 | - |
| Dec 31, 2023 | 8 | 0 | - |
| Dec 31, 2022 | 8 | 0 | - |
| Dec 31, 2021 | 8 | 1 | 14.29% |
| Mar 31, 2021 | 7 | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Aptevo Therapeutics | 33 |
| GeoVax Labs | 19 |
| Cardio Diagnostics Holdings | 17 |
| TransCode Therapeutics | 12 |
| NuCana | 12 |
| Enveric Biosciences | 6 |
| Mustang Bio | 4 |
| Silo Pharma | 3 |
DRMA News
- 2 months ago - Dermata Therapeutics Registration statement: Registration filing - Filings
- 2 months ago - Dermata Therapeutics Provides Corporate Update and Reports Financial Results for the First Quarter 2026 - Accesswire
- 2 months ago - Dermata Therapeutics Quarterly report: Q1 2026 - Filings
- 2 months ago - Dermata Therapeutics Earnings release: Q1 2026 - Filings
- 3 months ago - Dermata Therapeutics Proxy statement: Proxy filing - Filings
- 3 months ago - Dermata Therapeutics Proxy statement: Proxy filing - Filings
- 4 months ago - Dermata Therapeutics Proxy statement: Proxy filing - Filings
- 4 months ago - Dermata receives notice of acceptance of Australian patent application - TheFly